582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial

التفاصيل البيبلوغرافية
العنوان: 582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial
المؤلفون: Olea, Julian, Dadrastoussi, Homa, Hernandez, Eduardo Fernandez, Martinez, Hugo Lara, Wu, Kaijin, Loghmani, Houra, Heineman, Thomas, Trauger, Richard, Coffey, Matt, Salvador, Fernando, Gavilá, Joaquín, Pascual, Tomás, Manso, Luis, Prat, Aleix, Merchant, Akil, Kelly, Kevin
المصدر: Regular and Young Investigator Award Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2023
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2023-sitc2023.0582
DOI: 10.1136/jitc-2023-SITC2023.0582
الإتاحة: https://doi.org/10.1136/jitc-2023-sitc2023.0582Test
حقوق: http://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.3F43A306
قاعدة البيانات: BASE